Pluristem: third critically ill patient successfully treated with PLX cells Pluristem Therapeutics announced that the company's Placental eXpanded, or PLX, cells were successfully administered to a third patient in Hadassah Medical Center; thus, a series of three life saving compassionate use treatments were completed. The outcome of those treatments potentially suggests that the company's PLX cells may have significant potential to treat a range of indications of bone marrow diseases.
News For PSTI From The Last 14 Days
Check below for free stories on PSTI the last two weeks.